 The currently used method to evaluate altered glucose metabolism in patients with CF is an annual oral glucose tolerance test OGTT with the glucose value after 120 min after oral ingestion of glucose-fluid as reference. This method may detect CFRD much later than we see deterioration of lung function and weight loss. This deterioration and the mortality in CF is related to CFRD. 